Peer-influenced content. Sources you trust. No registration required. This is HCN.
MD Newsline
This phase 2 study underscores the challenges in enhancing therapeutic outcomes in metastatic castration-resistant prostate cancer with AZD4635 combined with immunotherapy, indicating a minimal PSA response among treated patients.
Oncology, Medical May 6th 2024
Northwestern Medicine
In cases of prostate cancer post-aquablation therapy, managing residual tissue and persistent PSA levels poses significant challenges for surgical intervention, as detailed by Dr. Edward M. Schaeffer.
Cleveland Clinic Journal of Medicine
The new consensus on urine culture practices emphasizes reducing unnecessary antibiotic use by refining diagnostic criteria and testing protocols, thus supporting robust antimicrobial stewardship.
Urology April 29th 2024
TheBodyPro
The “Effectiveness of PrEPTECH” trial reveals telehealth’s potential and challenges in initiating and sustaining PrEP adherence among at-risk groups, emphasizing the necessity for integrated community support in healthcare strategies.
Infectious Diseases April 22nd 2024
MDLinx
In the evolving landscape of erectile dysfunction treatment, alternative therapies offer hope beyond first-line medications. Current research and guidelines underscore the importance of comprehensive patient evaluation and the cautious integration of new therapeutic options.
Family Medicine/General Practice April 16th 2024
Microscopic colitis, often masked in routine diagnostic evaluations, necessitates a histological approach for accurate diagnosis. The disease’s association with specific medications underscores the need for careful patient medication reviews.
Gastroenterology April 15th 2024